Skip to main content
Elsevier
View Cart

Books in Immunology

Elsevier's Immunology collection equips researchers with valuable insights to address the complexities of the immune system and its role in health and disease, offering original research, insightful analysis, and current theory on diagnosing, managing, and advancing treatments for allergies, asthma, and immunologic disorders.

BooksJournals

    • Advances in Immunology

      • 1st Edition
      • Volume 168
      • May 1, 2026
      • English
      • Hardback
        9 7 8 0 4 4 3 3 1 3 8 6 8
      • eBook
        9 7 8 0 4 4 3 3 1 3 8 7 5
      Advances in Immunology, Volume 168, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology.

    • Inflammation and Cancer

      • 1st Edition
      • May 1, 2026
      • Anoop Kumar + 4 more
      • English
      • Paperback
        9 7 8 0 4 4 3 3 6 5 0 0 3
      • eBook
        9 7 8 0 4 4 3 3 6 5 0 1 0
      Inflammation and Cancer: Mechanisms, Diagnosis, and Therapeutic Strategies delves into the intricate relationship between inflammation and cancer, a crucial area of contemporary biomedical research. The book addresses the pressing need to understand how inflammatory processes contribute to cancer initiation, progression, and metastasis. By bridging theoretical frameworks with rigorous investigations, this comprehensive guide offers invaluable insights for researchers, clinicians, and students aiming to advance cancer biology and immunotherapeutic strategies. The book is structured into fifteen meticulously detailed chapters. It begins with an overview of inflammation's role in cancer, discussing molecular connections and signaling pathways. Subsequent chapters explore inflammatory pathways in various cancers, including breast, oral, lung, prostate, skin, and gastrointestinal cancers. Each chapter, authored by experts from renowned institutions worldwide, provides an in-depth analysis of specific inflammatory mechanisms and their implications in cancer development. The book also covers tumorigenesis, metastasis, preventive strategies, inflammatory biomarkers for cancer diagnosis, and innovative therapeutic designs. The final chapters focus on the dual role of platelets, targeting tumor-associated macrophages, novel treatment approaches, and recent advances in the field. This title offers substantial benefits to researchers, clinicians, and healthcare professionals by providing a thorough understanding of the cellular and molecular pathways linking inflammation and cancer, aiding in the development of effective anti-cancer immunotherapies. By highlighting the latest research and potential therapeutic strategies, this book serves as an essential resource for anyone dedicated to combating cancer through innovative and informed immunotherapeutic approaches.

    • Emerging Trends and Imminent Applications in Immunology and Pharmaceutical Biotechnology

      • 1st Edition
      • May 1, 2026
      • Swagat Kumar Das + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 7 5 1 7 3
      • eBook
        9 7 8 0 4 4 3 2 7 5 1 8 0
      Immerse yourself in the interdisciplinary dynamic world of immunology and pharmaceutical biotechnology with Emerging Trends and Imminent Applications in Immunology and Pharmaceutical Biotechnology. This detailed reference delves into historical perspectives, current trends, and future projections for research and development of immunological and biopharmaceutical products. This book is comprised of two sections. The first explores the diverse landscape of immunology with chapters on immunostimulants, natural and synthetic immunostimulants in aquaculture and animal husbandry, immunomodulators, immune boosters, pre- and probiotics in health promotion, cutting-edge immunological techniques for disease diagnosis, immunotherapy in cancer treatment, and transplantation immunology. The next builds upon this information to explore the impact on pharmaceutical biotechnology with discussions on traditional and modern approaches in drug delivery, in silico drug delivery modeling, biocomposites and their pharmaceutical applications, recent advances in monoclonal antibodies production, vaccine development, and the exploration of bioactive compounds from medicinally important plants. Additionally, discover the pivotal role of AI, machine learning, and data analytics in the clinical study of immunotherapy and pharmaceutical drugs, paving the way for enhanced research and development efficiency. Researchers in industry and academia alike will gain valuable insights into the novel principles behind designing and developing immunological and drug products, making this title an essential resource.

    • Microbiome in Head and Neck Cancer: Pathogenesis, Diagnosis and Therapeutic Implications

      • 1st Edition
      • Volume 169
      • May 1, 2026
      • English
      • Hardback
        9 7 8 0 4 4 3 4 7 0 5 2 3
      • eBook
        9 7 8 0 4 4 3 4 7 0 5 3 0
      Microbiome in Head and Neck Cancer: Pathogenesis, Diagnosis and Therapeutic Implications, Volume 169 in the Advances in Immunology series, presents an authoritative exploration of how microbial communities contribute to the initiation, progression, and treatment of head and neck cancers. This volume examines the composition and dynamics of the head and neck microbiome, key factors driving dysbiosis, and mechanistic links to oral potentially malignant disorders (OPMDs) and oral squamous cell carcinoma (OSCC). Chapters highlight emerging microbial biomarkers for early detection, the prognostic value of microbiome profiles, and innovative diagnostic and therapeutic approaches, including microbiome modulation and AI-based data analysis. Together, these insights provide clinicians, immunologists, oncologists, and cancer researchers with a comprehensive resource on the immunological and microbial interplay underlying head and neck malignancies.

    • The Microbiome and Cancer Treatment

      • 1st Edition
      • April 2, 2026
      • Sadhna Aggarwal + 3 more
      • English
      • Paperback
        9 7 8 0 4 4 3 3 3 2 0 6 7
      • eBook
        9 7 8 0 4 4 3 3 3 2 0 7 4
      “The Microbiome and Cancer Treatment: Overcoming Resistance and Enhancing Efficacy” delves into the intricate relationship between the microbiome and cancer treatment, highlighting the microbiome's critical role in drug resistance and therapeutic efficacy. The chapters are meticulously organized to provide a deep understanding of how the microbiome interacts with the immune system and influences cancer development and response to therapies. This book opens new avenues for investigation by providing a better understanding of the mechanisms of resistance and the role of microbiome alterations in chemoresistance. This knowledge can guide the development of innovative strategies to counteract drug resistance. The book also addresses the complex "chicken-or-egg" relationship between microbiome alterations and chemoresistance. A diverse blend of chapters fosters interdisciplinary collaboration across fields such as immunology, microbiology, oncology, and pharmacology, promoting holistic approaches to cancer treatment. The audience can benefit by gaining awareness and a better understanding of how the microbiome impacts health, particularly in the context of cancer, leading to more informed health choices.

    • Immunological Aspects of Preterm Birth

      • 1st Edition
      • April 1, 2026
      • Irina Burd MD
      • English
      • Paperback
        9 7 8 0 4 4 3 2 1 5 6 4 3
      • eBook
        9 7 8 0 4 4 3 2 1 5 6 5 0
      Immunological Aspects of Preterm Birth: Phenotypes of Preterm Birth, Immune Mechanisms, and Pathway Forward bridges reproductive immunology of preterm birth to subtypes, phenotypes, and bedside prevention and treatment. The book reviews the role of the different immune mechanisms during pregnancy that lead to preterm birth, along with the fetal programming effects that are connected to maternal immune activation. In addition, it discusses immune cells and their products and cytokines and chemokines as central for the success of the pregnancy.While our knowledge on the role of immune cells and the inflammatory process in preterm birth has grown exponentially in the last 10 years, connecting basic science to clinical science and the development of new therapeutics has not progressed as rapidly. This book assists researchers in understanding the basic immunologic mechanisms and inflammatory processes associated with preterm birth and fills an urgent need for the development of therapeutics in this space.

    • Immunological Insights and Emerging Therapeutics in Medical Mycology

      • 1st Edition
      • April 1, 2026
      • Paschalis Vergidis + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 3 6 3 6 5
      • eBook
        9 7 8 0 4 4 3 2 3 6 3 5 8
      Immunological Insights and Emerging Therapeutics in Medical Mycology summarizes the current knowledge on interactions between host cells and human fungal pathogens and explains how certain immune defects lead to vulnerability to fungal infection.Chapters focus on immune response to such fungal infections as candidiasis, aspergillus, cryptococcosis, mucormycosis, pneumocystis.This title provides a basis for further study on antifungal immunity by enhancing understanding of antifungal immune responses. Further, this title offers new insights from the host immune response, improving understanding of disease pathogenesis and informing novel prophylactic and therapeutic approaches to fungal infections.

    • Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments

      • 1st Edition
      • April 1, 2026
      • Tuan Anh Nguyen + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 4 4 5 7 9 8
      • eBook
        9 7 8 0 4 4 3 4 4 5 8 0 4
      Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments provides a balanced exploration of the dual roles of nanotechnologies in oncology. Structured in four parts, the book begins with foundational knowledge of nanovaccines and nanomedicines, detailing their applications in cancer care and highlighting their precision in targeting cancer cells while reducing systemic toxicity. Importantly, the book addresses potential drawbacks, discussing side effects and safety concerns associated with these innovations. The final section emphasizes ethical, regulatory, and safety challenges, underscoring the need for careful oversight as nanotechnologies advance. For the academic audience, this book serves as a vital resource, offering insights that equip researchers and healthcare professionals to make informed decisions regarding clinical applications. Its focus on both the benefits and risks, alongside forward-looking perspectives, ensures that readers are well-prepared for future developments in the field of nanomedicine and cancer therapy.

    • Systemic Lupus Erythematosus

      • 3rd Edition
      • March 1, 2026
      • George C. Tsokos
      • English
      • Paperback
        9 7 8 0 4 4 3 3 3 9 5 7 8
      • eBook
        9 7 8 0 4 4 3 3 3 9 5 8 5
      Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects has been an essential resource for scientists and clinicians in this field since its original publication in 2015. The third edition of this work has been completely updated and expanded with the latest scientific and clinical developments in Systemic Lupus Erythematosus (SLE) to date. Contributors at the forefront of each topic come together to enhance content on epidemiology and diagnosis, pathogenesis, mechanisms of tissue damage, clinical aspects of the disease, antiphospholipid syndrome, and treatments. Also added is the latest information on new treatments, criteria, monogenic forms of lupus, insights on the role of microbiome, and advances in understanding disease pathogenesis. This must-have reference is an indispensable resource for specialists in the diagnosis and management of patients with SLE as well as early career or experienced investigators studying basic aspects of the disease. It is a tool for measurement of clinical activity for pharmaceutical development and basic research of the disease, and a key reference work for hospital libraries.

    • Comorbidities in Inflammatory Arthritis

      • 1st Edition
      • Volume 18
      • March 1, 2026
      • Fabiola Atzeni + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 3 7 2 2 5
      • eBook
        9 7 8 0 4 4 3 2 3 7 2 3 2
      Comorbidities in Inflammatory Arthritis, Volume 18 in Elsevier’s Handbook for Systemic Autoimmune Diseases series, provides an extensive review of the most recent research on various comorbidities and EAMs associated with inflammatory arthritis. The book emphasizes early detection, which is crucial for improving patient quality of life and survivability outcomes, as many adults with inflammatory arthritis also suffer from other chronic conditions. The book's chapters cover comorbidities and EAMs in both early and late disease stages.They delve into the mechanisms behind the development of these conditions and examine the impact of new treatment strategies specific to inflammatory arthritis and related diseases, including cardiovascular disease, metabolic syndrome, metabolic bone disease, infection, neoplasia, respiratory disease, gastrointestinal disorders, kidney issues, mental health conditions, and neurological diseases. This book serves as a valuable reference for researchers and clinicians focused on inflammatory arthritis and its associated conditions.

Related subjects

Applied immunology

Basic immunology

Immunological methods

Immunopathogenesis